Infertility  >>  goserelin acetate  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
NCT00948805: Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment

Unknown status
3
25
RoW
GnRH agonist, Ovidrel, Zoladex, Gonal, Control
University of Sao Paulo
Infertility
12/09
07/10
CRUK-OPTION, NCT00427245: Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

Completed
3
400
Europe
cyclophosphamide, goserelin acetate, adjuvant therapy, fertility assessment and management, neoadjuvant therapy
Anglo Celtic Cooperative Oncology Group
Breast Cancer, Infertility, Menopausal Symptoms
 
 
NCT00068601 / ACTRN12606000075583: S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

Completed
3
257
Europe, RoW
cyclophosphamide, goserelin acetate
Southwest Oncology Group, National Cancer Institute (NCI), Cancer and Leukemia Group B, Eastern Cooperative Oncology Group, ETOP IBCSG Partners Foundation
Breast Cancer, Infertility, Menopausal Symptoms
01/14
09/16

Download Options